Anbio Biotechnology Class A Ordinary Shares

NNNN· NASDAQ· Health Care· Health Care Equipment & Services

$5.25-6.25%

2026-09-18

Financials

Valuation Metrics

Anbio Biotechnology Class A Ordinary Shares's Market Cap is $230M. At end of 2025 it was $1.32B. Ranked #2987 of 3,121 in US market (top 96%), #1358 of 1,463 on NASDAQ (top 93%), #189 of 205 in Health Care Equipment & Services (top 92%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$230M	US#2,987/3,121 Sec#189/205
Total Assets	$30M	US#3,088/3,121 Sec#205/205
Net Assets	$30M	US#2,886/3,121 Sec#187/205
Value
P/B	7.64x	US#2,535/3,121 Sec#161/205
P/S	26.65x	US#2,885/3,121 Sec#202/205
Profitability
Revenue Growth	5.64%	US#1,744/3,121 Sec#124/205
Earnings Growth	169.86%	US#183/3,121 Sec#9/205
Financial Health
Debt Ratio	0.29%	US#5/3,121 Sec#1/205
Total Debt	$0.00	US—/3,121 Sec—/205
Cash	$8M	US#3,002/3,121 Sec#202/205
Current Ratio	344.31x	US#19/3,121 Sec#1/205
Performance
1Y Return	-87.62%	US#3,120/3,121 Sec#205/205
1M Return	-32.26%	US#3,089/3,121 Sec#204/205
From 52W High	-89.77%	US#3,116/3,121 Sec#205/205
1Y MDD	-87.67%	US#3,102/3,121 Sec#204/205
Trading
Volume	289,738 shares	US#2,411/3,121 Sec#170/205
Trading Value	$2M	US#2,947/3,121 Sec#186/205
Per Share
BPS	$0.69	US#2,737/3,121 Sec#187/205